Skip to main content
March 26, 2026 in News, Press Releases

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PRN Newswire Release • Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology…
Read More
February 12, 2026 in Press Releases

Ponce Aurora Appoints Former Estee Lauder Executive as Chief Commercial Officer Ahead of Longevity Product Launches

Ponce Aurora is developing consumer products powered by its proprietary MitoXcel™ Technology, the first information- and AI-driven mitochondrial-targeted geropeptides addressing a fundamental cause of aging.  Appointment strengthens leadership team to drive market readiness for YUUTH- and…
Read More
February 22, 2025 in Press Releases

Brent Saunders Appointed as Advisory Board Chairman

Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 Miami, FL – February 26, 2025…
Read More
March 27, 2026 in News

Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses

Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Read More
March 26, 2026 in News

Pulmatrix and Eos merge to advance gerotherapeutics

Pulmatrix and Eos merge to advance gerotherapeutics
Read More
March 26, 2026 in News, Press Releases

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PRN Newswire Release • Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology…
Read More